Ge
No verificado

GenSight Biologics S.A.

Sobre qué escribimos

BiotecnologíaFarmacéuticaMedicina - VariosÓpticaSalud
18/02/2026
Salud
Biotecnología
Sanidad
Medicina - Varios
Óptica
Mercado laboral
GenSight Biologics Bolsters Regulatory Leadership in US and Europe with Two Senior Appointments
1.00
10/02/2026
Biotecnología
Farmacéutica
Óptica
Sanidad
Salud
Medicina - Varios
Mercado laboral
Industria
The 15-20 National Hospital and GenSight Biologics Announce the Treatment of the First Patient in the GS010/LUMEVOQ® REVISE Study
1.00
28/01/2026
Salud
Biotecnología
Medicina - Varios
Farmacéutica
Óptica
GenSight Biologics Announces the Results of its Extraordinary General Meeting of January 28, 2026
1.00
22/12/2025
Industria
Salud
Biotecnología
Medicina - Varios
Farmacéutica
Óptica
GenSight Biologics Announces Regulatory Authorization for Early Access Treatment with GS010/LUMEVOQ® in Israel
1.00
28/08/2025
Biotecnología
Farmacéutica
Salud
Mercado de valores
Finanzas
Web y redes sociales
Telefonía
GenSight Biologics Postpones Release of 2025 Half-Year Financial Results
1.00
08/04/2025
Biotecnología
Salud
Farmacéutica
Óptica
GenSight Biologics Announces the Filing of its 2024 Universal Registration Document
1.00
27/02/2025
Biotecnología
Salud
Farmacéutica
Óptica
Mercado de valores
GenSight Biologics Reports Estimated Full-Year 2024 Consolidated Financial Results
1.00
15/01/2025
Industria
Salud
Biotecnología
Medicina - Varios
Farmacéutica
Óptica
GenSight Biologics Announces Publication of 5-Year Outcomes for Patients Treated Unilaterally with LUMEVOQ® Gene Therapy
1.00
18/12/2024
Biotecnología
Farmacéutica
Óptica
Salud
GenSight Biologics Provides Update on Regulatory Discussions and Financial Situation
1.00

Detalles de contacto

Redes sociales

Seguidores
0
Compatibilidad
0